Evidence map›Paper›PMID 18372928›Full record

ArticleNeuron glia biology2007

Cytoskeletal transition at the paranodes: the Achilles' heel of myelinated axons.

Aurea D Sousa, Manzoor A Bhat

Open access · greenAbstract read
In one paragraph

Article in Neuron glia biology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Protective effects of edaravone on white matter pathology in a novel mouse model of Alzheimer's disease with chronic cerebral hypoperfusion.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2021
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Axonal ensheathment and intercellular barrier formation in Drosophila.International review of cell and molecular biology · 2010
    Review
  9. Article
  10. Article
  11. Myelination and regional domain differentiation of the axon.Results and problems in cell differentiation · 2009
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Aurea D SousaDepartment of Cell and Molecular Physiology, Curriculum in Neurobiology, Neurodevelopmental Disorders Research Center and UNC-Neuroscience Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Manzoor A Bhat
NeuroDevelopment Center · US

Funding

Molecular Organization &Function of Paranodal JunctionsR01GM063074 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BHAT, MANZOOR A. · 2001 to 2023
$5.8M
Molecular Characterization of Axon-Glial InteractionsR01NS050356 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BHAT, MANZOOR A. · 2006 to 2016
$2.9M
NIGMS NIH HHS R01 GM063074NINDS NIH HHS R01 NS050356
6 · The paper itself

Abstract

Myelination organizes axons into distinct domains that allow nerve impulses to propagate in a saltatory manner. The edges of the myelin sheath are sealed at the paranodes by axon-glial junctions that have a crucial role in organizing the axonal cytoskeleton. Here we propose a model in which the myelinated axons depend on the axon-glial junctions to stabilize the cytoskeletal transition at the paranodes. Thus paranodal regions are likely to be particularly susceptible to damage induced by demyelinating diseases such as multiple sclerosis.

Indexed as

axonal cytoskeletonaxon-glial junctionsCaspr (contactin-associated protein)cytoskeletal transitionMyelinNCP1node of Ranvierparanodeparanodin

Identifiers

PMID18372928
PMCPMC2276405
OpenAlexW2067906947

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.